Cited by 33Adrenal and Paraganglionic TumorsAdrenal Hormones and DisordersNeuroendocrine Tumor Research Advances

Pathology of the adrenal cortex: a reappraisal of the past 25 years focusing on adrenal cortical tumors

Open access
Papotti, Mauro, Duregon, Eleonora, Volante, Marco, McNicol, Anne Marie·2014·Endocrine Pathology

Abstract

A reappraisal of the major advances in the diagnostic pathology of adrenal cortical lesions and tumors in the last 25 years is presented, with special reference to the definition of malignancy in primary adrenal cancer and its variants. Slightly more than 25 years ago, Weiss proposed his diagnostic scoring system for adrenal cortical carcinoma. This represented a milestone for adrenal pathologists and the starting point for further modifications of the system, either through minor changes in the scoring procedure itself or concentrating on some particular Weiss criterion such as mitotic index, integrated into alternative scoring schemes or algorithms that are currently under validation. Improvements in diagnostic immunohistochemistry have led to the identification of markers of cortical origin, such as Melan-A, alpha-inhibin, and SF-1 and of prognostic factors in carcinoma, such as the Ki-67 proliferation index and SF-1 itself. With regard to hyperplastic conditions, genetic investigations have allowed the association of the majority of cases of primary pigmented nodular adrenocortical disease (PPNAD) in Carney complex to mutations in the gene encoding the regulatory subunit 1A of protein kinase A (PRKAR1A). Other hereditary conditions are also associated with adrenal cortical tumors, including the Li-Fraumeni, Beckwith-Wiedemann, Gardner, multiple endocrine neoplasia type 1, and neurofibromatosis type 1 syndromes. Moreover, several advances have been made in the knowledge of the molecular background of sporadic tumors, and a number of molecules/genes are of particular interest as potential diagnostic and prognostic biomarkers.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s12022-013-9291-6

Cites

118 of 118 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The final diagnosis of ACC is histological and requires the input of an experienced adrenal pathologist.

    “Although there are several clinical, endocrinological and radiological features that help risk stratify an adrenal lesion with regard to the likelihood of ACC (see “Etiology and clinical presentation of AI”), the final diagnosis is a histological one and requires the input of an experienced adrenal pathologist (110).”

    From Adrenal incidentaloma (2020) · cites this paper as [110]

  • The most widely used histological scoring system for ACC is the Weiss score, based on 9 histological parameters.

    “The most widely used histological scoring system is the Weiss score (Table 4) based on 9 histological parameters (scored as 0 if absent and 1 if present) (110,111).”

    From Adrenal incidentaloma (2020) · cites this paper as [110]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

2 of the 120 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

  1. [4]4. Lau SK, Weiss LM (2009) The Weiss system for evaluating adrenocortical neoplasms: 25 years later. Hum Pathol 40 (6):757-768. doi:S0046-8177(09)00083-5 [pii]
  2. [5]5. Blanes A, Diaz-Cano SJ (2007) Histologic criteria for adrenocortical proliferative lesions: value of mitotic figure variability. Am J Clin Pathol 127 (3):398-408. doi:F7G613581L18603Q [pii]

Cited by

Sorted by citations

Authors
Papotti, M., Duregon, E., Volante, M., & McNicol, A. M.
Affiliations
  • Ospedale San Luigi Gonzaga (IT)
  • The University of Queensland (AU)
Corresponding author
Volante, Marco
Venue
Endocrine Pathology
Published
2014-01-03
Volume
25
Issue
1
Pages
35-48
ISSN
  • 1046-3976 (ISSN-L)
  • 1559-0097
OpenAlex
W2094125338
Cited by
33
References
120
Citations by year
2026: 1 · 2022: 4 · 2021: 1 · 2020: 3 · 2019: 2 · 2018: 3 · 2017: 4 · 2016: 4 · 2015: 8 · 2014: 3
FWCI
6.28
Type
journal article
Language
en
Open access
Locations
  • Endocrine Pathology (publishedVersion)
  • PubMed (publishedVersion)
  • Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
Funders
  • Associazione Italiana per la Ricerca sul Cancro (IG/10795/2010)
  • Università degli Studi di Torino (IG/10795/2010)
Topics
  • Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Epidemiology › Neuroendocrine Tumor Research Advances
Keywords
adrenocortical tumors, adrenocortical carcinoma, mitotic index, immunohistochemical markers, SF-1, Ki-67 proliferation index, primary pigmented nodular adrenocortical disease, Carney complex, PRKAR1A mutation, Li-Fraumeni syndrome, Beckwith-Wiedemann syndrome, Gardner syndrome, multiple endocrine neoplasia type 1, neurofibromatosis type 1, prognostic factors, adrenal hyperplasia
MeSH terms
Adrenal Cortex, Adrenal Cortex Neoplasms, Humans, Adrenocortical Adenoma, Adrenocortical Carcinoma, History, 20th Century, History, 21st Century

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review